3Chopt Investment Partners »

Regeneron Pharmaceuticals shares owned by 3Chopt Investment Partners

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by 3Chopt Investment Partners from 13F filings

Historical chart of 3Chopt Investment Partners investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by 3Chopt Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by 3Chopt Investment Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $526k 599 878.29
2023-06-30 $487k 677 718.54
2023-03-31 $1.0M 1.3k 821.67
2022-12-31 $978k 1.4k 721.49

More positions owned by 3Chopt Investment Partners

Vanguard S&P 500 ETF Etf (VOO)
Vanguard Small Cap ETF Etf (VB)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Alphabet Inc. Class C Common Stock (GOOG)
Berkshire Hathaway Class B Common Stock (BRK.B)
Microsoft Common Stock (MSFT)
NVR Common Stock (NVR)
McKesson Corp Common Stock (MCK)
Merck & Co Common Stock (MRK)
Broadcom Common Stock (AVGO)
Arch Cap Group LTD F Common Stock (ACGL)
Vanguard Small Cap Value ETF Etf (VBR)
Cisco Systems Common Stock (CSCO)
Meta Platforms Inc Class A Common Stock (META)

View all positions for 3Chopt Investment Partners

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
Jpmorgan Chase & Co
Dodge & Cox
Wellington Management Company
Norges Bank Investment Management
Legal & General Group
Bank of America Corporation
Bank of New York Mellon
Amundi
Citadel Advisors
Alliancebernstein
T. Rowe Price Associates
Ubs Global Asset Management Americas
Charles Schwab Investment Management
Dimensional Fund Advisors

View all funds holding Regeneron Pharmaceuticals